Oxidative stress in Rett syndrome: Natural history, genotype, and variants

Redox Report

Volumn 16, Issue 4, 2011, Pages 145-153

  Leoncini, Silvia ^a   de Felice, Claudio ^b   Signorini, Cinzia ^a   Pecorelli, Alessandra ^a   Durand, Thierry ^c   Valacchi, Giuseppe ^d,e   Ciccoli, Lucia ^a   Hayek, Joussef ^b  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY HOSPITAL OF SIENA   (Italy)

^c UNIVERSITÉ DE MONTPELLIER   (France)

^d UNIVERSITY OF FERRARA   (Italy)

^e Kyung Hee University   (South Korea)

Author keywords

Autism spectrum disorders; F 2 isoprostanes; MeCP2 gene; Non protein bound iron; Oxidative stress; Rett syndrome

Indexed keywords

BIOLOGICAL MARKER; DOCOSAHEXAENOIC ACID; DOCOSAHEXAENOIC ACID PLUS EICOSAPENTAENOIC ACID; ESKIM; ICOSAPENTAENOIC ACID; ISOPROSTANE DERIVATIVE; NON PROTEIN BOUND IRON; OMEGA 3 FATTY ACID; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; GAS CHROMATOGRAPHY; GAS CHROMATOGRAPHY NEGATIVE ION CHEMICAL IONIZATION TANDEM MASS SPECTROMETRY; GENE MUTATION; GENETIC HETEROGENEITY; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HISTORY; HUMAN; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; OXIDATIVE STRESS; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETT SYNDROME; SCHOOL CHILD; SEIZURE; TANDEM MASS SPECTROMETRY; TREATMENT RESPONSE;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; F2-ISOPROSTANES; FATTY ACIDS, OMEGA-3; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; METHYL-CPG-BINDING PROTEIN 2; MUTATION; OXIDATIVE STRESS; PHENOTYPE; RETT SYNDROME; TANDEM MASS SPECTROMETRY;

EID: 80052009849     PISSN: 13510002     EISSN: 17432928     Source Type: Journal    
DOI: 10.1179/1351000211Y.0000000004     Document Type: Article

References (49)

1. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. Rett syndrome is caused by mutation in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999;23(2):185-8.
2. Chahrour M, Zoghbi HY. The story of Rett syndrome: from clinic to neurobiology. Neuron 2007;56(3):422-37.
3. Mari F, Azimonti S, Bertani I, Bolognese F, Colombo E, Caselli R, et al. CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome. Hum Mol Genet 2005; 14(14):1935-46.
4. Ariani F, Hayek G, Rondinella D, Artuso R, Mencarelli MA, Spanhol-Rosseto A, et al. FOXG1 is responsible for the congenital variant of Rett syndrome. Am J Hum Genet 2008;83(1): 89-93.
5. Neul JL, Kaufmann WE, Glaze DG, Christodoulou J, Clarke AJ, Bahi-Buisson N, et al. Rett syndrome: revised diagnostic criteria and nomenclature. Ann Neurol 2010;68(6):944-50.
6. Hagberg B. Clinical manifestations and stages of Rett syndrome. Ment Retard Dev Disabil Res Rev 2002;8(2):61-5.
7. Calder PC, Yaqoob P. Understanding omega-3 polyunsaturated fatty acids. Postgrad Med 2009;121(6):148-57.
8. Christodoulou J, Grimm A, Maher T, Bennetts B. RettBASE: the IRSA MECP2 variation database - a new mutation database in evolution. Hum Mutat 2003;21(5):466-72.
9. Sampieri K, Meloni I, Scala E, Ariani F, Caselli R, Pescucci C, et al. Italian Rett database and biobank. Hum Mutat 2007;28(4): 329-35.
10. Belayev L, Khoutorova L, Atkins KD, Eady TN, Hong S, Lu Y, et al. Docosahexaenoic acid therapy of experimental ischemic stroke. Transl Stroke Res 2011;2(1):33-41.
11. Neul JL, Fang P, Barrish J, Lane J, Caeg EB, Smith EO, et al. Specific mutations in methyl-CpG-binding protein 2 confer different severity in Rett syndrome. Neurology 2008;70(16): 1313-21.
12. De Felice C, Ciccoli L, Leoncini S, Signorini C, Rossi M, Vannuccini L, et al. Systemic oxidative stress in classic Rett syndrome. Free Radic Biol Med 2009;47(4):440-8.
13. Signorini C, Comporti M, Giorgi G. Ion trap tandem mass spec-trometric determination of F2-isoprostanes. J Mass Spectrom 2003;38(10):1067-74.
14. Carouge D, Host L, Aunis D, Zwiller J, Anglard P. CDKL5 is a brain MeCP2 target gene regulated by DNA methylation. Neurobiol Dis 2010;38(3):414-24.
15. Renieri A, Mari F, Mencarelli MA, Scala E, Ariani F, Longo I, Meloni I, et al. Diagnostic criteria for the Zappella variant of Rett syndrome (the preserved speech variant). Brain Dev 2009; 31(3):208-16.
16. Pecorelli A, Ciccoli L, Signorini C, Leoncini S, Giardini A, D'Esposito M, et al. Increased levels of 4HNE-protein plasma adducts in Rett syndrome. Clin Biochem 2011; 44(5-6):368-71.
17. Balagopalakrishna C, Manoharan PT, Abugo OO, Rifkind JM. Production of superoxide from hemoglobin-bound oxygen under hypoxic conditions. Biochemistry 1996;35(20):6393-8.
18. Ciccoli L, Rossi V, Leoncini S, Signorini C, Paffetti P, Bracci R, et al. Iron release in erythrocytes and plasma non protein-bound iron in hypoxic and non hypoxic newborns. Free Radic Res 2003; 37(1):51-8.
19. Ciccoli L, Rossi V, Leoncini S, Signorini C, Blanco-Garcia J, Aldinucci C, et al. Iron release, superoxide production and binding of autologous IgG to band 3 dimers in newborn and adult erythrocytes exposed to hypoxia and hypoxia-reoxygenation. Biochim Biophys Acta 2004;1672(3):203-13.
20. Guy J, Gan J, Selfridge J, Cobb S, Bird A. Reversal of neurological defects in a mouse model of Rett syndrome. Science 2007; 315(5815):1143-7.
21. Tropea D, Giacometti E, Wilson NR, Beard C, McCurry C, Fu DD, et al. Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice. Proc Natl Acad Sci USA 2009;106(6): 2029-34.
22. Cobb S, Guy J, Bird A. Reversibility of functional deficits in experimental models of Rett syndrome. Biochem Soc Trans 2010;38(2):498-506.
23. Soderberg M, Edlund C, Kristensson K, Dallner G. Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease. Lipids 1991;26(6):421-5.
24. Gamoh S, Hashimoto M, Sugioka K, Shahdat Hossain M, Hata N, Misawa Y, et al. Chronic administration of docosahexaenoic acid improves reference memory-related learning ability in young rats. Neuroscience 1999;93(1):237-41.
25. McGahon BM, Martin DS, Horrobin DF, Lynch MA. Age-related changes in synaptic function: analysis of the effect of dietary supplementation with omega-3 fatty acids. Neuroscience 1999;94(1):305-14.
26. Belayev L, Marcheselli VL, Khoutorova L, Rodriguez de Turco EB, Busto R, Ginsberg MD, et al. Docosahexaenoic acid com-plexed to albumin elicits high-grade ischemic neuroprotection. Stroke 2005;36(1):118-23.
27. Serhan CN, Gotlinger K, Hong S, Lu Y, Siegelman J, Baer T, et al. Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-con-taining docosatrienes. J Immunol 2006;176(3):1848-59.
28. Simopoulos AP. Evolutionary aspects of diet: the omega-6/ omega-3 ratio and the brain. Mol Neurobiol 2011; Epub, DOI: 10.1007/s12035-010-8162-0.
29. Hagiwara H, Nishiyama Y, Katayama Y. Effects of eicosapen-taenoic acid on asymmetric dimethylarginine in patients in the chronic phase of cerebral infarction: a preliminary study. J Stroke Cerebrovasc Dis 2011; Epub, DOI: 10.1016/j.jstroke cerebrovasdis 2010.12.006.
30. Maezawa I, Jin LW. Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate. J Neurosci 2010;30(15):5346-56.
31. Kifayathullah LA, Arunachalam JP, Bodda C, Agbemenyah HY, Laccone FA, Mannan AU. MeCP2 mutant protein is expressed in astrocytes as well as in neurons and localizes in the nucleus. Cytogenet Genome Res 2010;129(4):290-7.
32. Maezawa I, Swanberg S, Harvey D, LaSalle JM, Jin LW. Rett syndrome astrocytes are abnormal and spread MeCP2 deficiency through gap junctions. J Neurosci 2009;29(16):5051-61.
33. Ballas N, Lioy DT, Grunseich C, Mandel G. Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology. Nat Neurosci 2009;12(3):311-7.
34. Signorini C, De Felice C, Leoncini S, Giardini A, D'Esposito M, Filosa S, et al. F4-neuroprostanes mediate neurological severity in Rett syndrome. Clin Chim Acta 2011;412(15-16):1399-1406.
35. Gitschier J. On the tracks of DNA methylation: an interview to Adrian Bird. PLOS Genet 2009;5:e1000667. DOI: 10.1371/ journal.pgen.1000667.
36. Halliwell B, Gutteridge JMC. Free radicals, other reactive species and disease. In: Halliwell B, Gutteridge JMC (eds.) Free radicals in biology and medicine. Oxford: Clarendon Press; 1999. p. 617-783.
37. Seet RC, Lee CY, Lim EC, Tan JJ, Quek AM, Chong WL, et al. Oxidative damage in Parkinson disease: measurement using accurate biomarkers. Free Radic Biol Med 2010;48(4):560-6.
38. Sierra C, Vilaseca MA, Brandi N, Artuch R, Mira A, Nieto M, et al. Oxidative stress in Rett syndrome. Brain Dev 2001;23(S1): 236-9.
39. Rett A. Uber ein eigartiges hirnatrophisches Syndrom bei Hyperammoniamie in Kindesalter. Wien Med Wochenschr 1966;116(37):723-6.
40. Lintas C, Sacco R, Persico AM. Genome-wide expression studies in Autism spectrum disorder, Rett syndrome, and Down syndrome. Neurobiol Dis 2010; Epub, DOI: 10.1016/j.nbd.2010. 11.010.
41. Ruch A, Kurczynski TW, Velasco ME. Mitochondrial alterations in Rett syndrome. Pediatr Neurol 1989;5(5):320-3.
42. Wakai S, Kameda K, Ishikawa Y, Miyamoto S, Nagaoka M, Okabe M, et al. Rett syndrome: findings suggesting axonopathy and mitochondrial abnormalities. Pediatr Neurol 1990;6(5): 339-43.
43. Cornford ME, Philippart M, Jacobs B, Scheibel AB, Vinters HV. Neuropathology of Rett syndrome: case report with neuronal and mitochondrial abnormalities in the brain. J Child Neurol 1994;9(4):424-31.
44. Coker SB, Melnyk AR. Rett syndrome and mitochondrial enzyme deficiencies. J Child Neurol 1991;6(2):164-6.
45. Heilstedt HA, Shahbazian MD, Lee B. Infantile hypotonia as a presentation of Rett syndrome. Am J Med Genet 2002;111(3): 238-42.
46. Finsterer J. Mitochondriopathies. Eur J Neurol 2004;11(3): 163-86.
47. Gibson JH, Slobedman B, Kaipananickal H, Williamson SL, Minchenko D, El-Osta A, Stern JL, et al. Downstream targets of methyl CpG binding protein 2 and their abnormal expression in the frontal cortex of the human Rett syndrome brain. BMC Neurosci 2010;11:53.
48. Kriaucionis S, Paterson A, Curtis J, Guy J, MacLeod N, Bird A. Gene expression analysis exposes mitochondrial abnormalities in a mouse model of Rett syndrome. Molec Cell Biol 2006;26(13): 5033-42.
49. Zoghbi HY, Warren ST. Neurogenetics: advancing the "next-generation" of brain research. Neuron 2010;68(2):165-73.